InfraReDx Obtains $21,000,000 Series D Round

  • Feed Type
  • Date
    10/12/2010
  • Company Name
    InfraReDx
  • Mailing Address
    34 Third Avenue Burlington, MA 01803
  • Company Description
    The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical study.
  • Website
    http://www.infraredx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Funds from the financing are being used to support the full commercial launch of the LipiScan IVUS Coronary Imaging System, the world’s first and only intravascular imaging system that combines and co-registers grayscale intravascular ultrasound (IVUS) with InfraReDx’s proprietary near infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology.
  • M&A Terms
  • Venture Investor
    Sanderling Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.